Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Anders

Showing results (231-240 of 247) with videos related to

Pageof 25
Sort By:
Blood|October 17, 2025
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert PanelC Michel Zwaan, Sarah K Tasian, Richard Aplenc, et al.
Harmful Algae|June 8, 2023
The Western Lake Erie culture collection: A promising resource for evaluating the physiological and genetic diversity of Microcystis and its associated microbiomeColleen E Yancey, E Anders Kiledal, Subba Rao Chaganti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor ModelsCaitlin D Lowery, Michele Dowless, Matthew Renschler, et al.
Nature Communications|September 19, 2022
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemiaBenjamin J Huang, Jenny L Smith, Jason E Farrar, et al.
Frontiers in Cardiovascular Medicine|December 18, 2023
Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapyKasey J Leger, Nora Robison, Hari K Narayan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology GroupSteven G DuBois, Mark D Krailo, Julia Glade-Bender, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2026
PRECLINICAL ACTIVITY OF THE B7-H3- TARGETING ANTIBODY-DRUG CONJUGATE (ADC) VOBRAMITAMAB DUOCARMAZINE (VOBRA DUO) IN PEDIATRIC SOLID TUMORSEdward Favours, Haiying Tang, Peyton Wong, et al.
Blood Advances|February 3, 2023
Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndromeNikhil Raghuram, Daisuke Hasegawa, Kentaro Nakashima, et al.
Nature Communications|July 29, 2025
Epigenomic diagnosis and prognosis of Acute Myeloid LeukemiaFrancisco Marchi, Vivek M Shastri, Richard J Marrero, et al.
Nature Medicine|April 11, 2018
Erratum: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactionsHamid Bolouri, Jason E Farrar, Timothy Triche, et al.
Pageof 25

Showing results (231-240 of 247) with videos related to

Sort By:
Pageof 25
Blood|October 17, 2025
Diagnosis and Management of AML in Pediatric Patients: Consensus Recommendations from an International Expert PanelC Michel Zwaan, Sarah K Tasian, Richard Aplenc, et al.
Harmful Algae|June 8, 2023
The Western Lake Erie culture collection: A promising resource for evaluating the physiological and genetic diversity of Microcystis and its associated microbiomeColleen E Yancey, E Anders Kiledal, Subba Rao Chaganti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor ModelsCaitlin D Lowery, Michele Dowless, Matthew Renschler, et al.
Nature Communications|September 19, 2022
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemiaBenjamin J Huang, Jenny L Smith, Jason E Farrar, et al.
Frontiers in Cardiovascular Medicine|December 18, 2023
Rationale and design of the Children's Oncology Group study AAML1831 integrated cardiac substudies in pediatric acute myeloid leukemia therapyKasey J Leger, Nora Robison, Hari K Narayan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology GroupSteven G DuBois, Mark D Krailo, Julia Glade-Bender, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2026
PRECLINICAL ACTIVITY OF THE B7-H3- TARGETING ANTIBODY-DRUG CONJUGATE (ADC) VOBRAMITAMAB DUOCARMAZINE (VOBRA DUO) IN PEDIATRIC SOLID TUMORSEdward Favours, Haiying Tang, Peyton Wong, et al.
Blood Advances|February 3, 2023
Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndromeNikhil Raghuram, Daisuke Hasegawa, Kentaro Nakashima, et al.
Nature Communications|July 29, 2025
Epigenomic diagnosis and prognosis of Acute Myeloid LeukemiaFrancisco Marchi, Vivek M Shastri, Richard J Marrero, et al.
Nature Medicine|April 11, 2018
Erratum: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactionsHamid Bolouri, Jason E Farrar, Timothy Triche, et al.
Pageof 25